Takayasu arteritis;Maladie de Takayasu

Presse Medicale

Volumn 35, Issue 5 II, 2006, Pages 847-856

  Quéméneur, Thomas ^a,b   Hachulla, Éric ^a   Lambert, Marc ^a   Perez Cousin, Maryse ^a   Queyrel, Viviane ^a   Launay, David ^a   Morell Dubois, Sandrine ^a   Hatron, Pierre Yves ^a  

^a LILLE UNIVERSITY HOSPITAL   (France)

^b Hôpital de Valenciennes 59   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; FLUORODEOXYGLUCOSE F 18;

AGE DISTRIBUTION; AGGRESSIVENESS; AORTA ANEURYSM; AORTA ARCH SYNDROME; AORTA STENOSIS; AORTA THROMBOSIS; AORTA VALVE REGURGITATION; ARTERY INTIMA PROLIFERATION; CLINICAL PROTOCOL; CORTICOSTEROID THERAPY; DIAGNOSTIC ACCURACY; DIAGNOSTIC APPROACH ROUTE; DISEASE MARKER; DOPPLER FLOWMETRY; DOSE CALCULATION; HUMAN; HYPERTENSION; POSITRON EMISSION TOMOGRAPHY; RETINOPATHY; REVIEW; SEX DIFFERENCE; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT DURATION; VASCULAR SURGERY;

EID: 33646724313     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0755-4982(06)74703-0     Document Type: Article

References (50)

1. Hall S, Barr W, Lie JT, Stanson AW, Kazmier FJ, Hunder GG. Takayasu arteritis. A study of 32 North American patients. Medicine (Baltimore). 1985; 64: 89-99.
2. Waern AU, Andersson P, Hemmingsson A. Takayasu's arteritis: a hospital-region based study on occurrence, treatment and prognosis. Angiology. 1983; 34: 311-20.
3. Kerr GS, Hallahan CW, Gordano J, Leavitt RY, Fauci AS, Rottem M et al. Takayasu arteritis. Ann Intern Med. 1994; 120: 919-29.
4. FiessingerJN, Tawkik-Taher S, Capron L, Laurian C, Cormier JM, Camilleri JP et al. Takayasu's disease diagnostic criteria. Nouv Presse Med. 1982; 11: 583-6.
5. Lambert M, Hachulla E, Hatron PY, Perez-Cousin M, Berregi JP, Warembourg H, Devulder B. Artérite de Takayasu: explorations vasculaires et prise en charge t hérapeutique. Expérience à propos de 16 patients. Rev Med Interne. 1998; 19: 878-84
6. Subramanyan R, Joy J, Balakrishnan KG. Natural history of aortoarteritis (Takayasu's disease). Circulation. 1989; 80: 429-37.
7. Vanoli M, Daina E, Sabbadini MG, Rossi C, Bacchiani G, Schieppati A; Itaka Study Group. Takayasu's arteritis: A study of 104 Italian patients. Arthritis Rheum. 2005; 53: 100-7.
8. Lupi-Herrera E, Sanchez-Torres G, Marcushamer J, Mispireta J, Horwitz S, Vela JE. Takayasu's arteritis. Clinical study of 107 cases. Am Heart J. 1977; 93: 94-103.
9. Ishikawa K Natural history and classification of occlusive thromboaortopathy (Takayasu's disease). Circulation. 1978; 57: 27-35.
10. Vanoli M, Castellani M, Bacchiani G, Cali G, Mietner B, Origgi L et al. Non-invasive assessment of pulmonary artery involvement in Takayasu's arteritis. Clin Exp Rheumatol. 1999; 17: 215-8.
11. Sharma BK, Jain S, Suri S, Numano F. Diagnostic criteria for Takayasu arteritis. Int J Cardiol. 1996; 54 (Suppl): S141-7.
12. Aggarwal A, Chag M, Sinha N, Naik S. Takayasu's arteritis: role of Mycobacterium tuberculosis and its 65 kDa heat shock protein. Int J Cardiol. 1996; 55: 49-55.
13. Kasuya K, Hashimoto Y, Numano F. Left ventricular dysfunction and HLA Bw52 antigen in Takayasu arteritis. Heart Vessels Suppl. 1992; 7: 116-9.
14. Yoshida M, Kimura A, Katsuragi K, Numano F, Sasazuki T. DNA typing of HLA-B gene in Takayasu's arteritis. Tissue Antigens. 1993; 42: 87-90.
15. Noris M, Daina E, Gamba S, Bonazzola S, Remuzzi G. Interleukin-6 and RANTES in Takayasu arteritis: a guide for therapeutic decisions? Circulation. 1999; 100: 55-60.
16. Arend WP, Michel BA, Bloch DA, Hunder GG, Calabrese LH, Edworthy et al. The American College of Rheumatology 1990 criteria for the classification of Takayasu arteritis. Arthritis Rheum. 1990; 33: 1129-34.
17. Cantu C, Pineda C, Barinagarrementeria F, Salgado P, Gurza A, Paola de Pablo et al. Noninvasive cerebrovascular assessment of Takayasu arteritis. Stroke. 2000; 31: 2197-202.
18. Sun Y, Yip PK, Jeng JS, Hwang BS, Lin WH. Ultrasonographic study and long-term follow-up of Takayasu's arteritis. Stroke. 1996; 27: 2178-82.
19. Yamada I, Nakagawa T, Himeno Y, Numano F, Shibuya H. Takayasu arteritis: evaluation of the thoracic aorta with CT angiography. Radiology. 1998; 209: 103-9.
20. Yamada I, Nakagawa T, Himeno Y, Kobayashi Y, Numano F, Shibuya H. Takayasu arteritis: diagnosis with breath-hold contrast-enhanced three-dimensional MR angiography. J Magn Reson Imaging. 2000; 11: 481-7.
21. Schmidt WA, Nerenheim A, Seipelt E, Poehls C, Gromnica-Ihle E. Diagnosis of early Takayasu arteritis with sonography. Rheumatology (Oxford). 2002; 41: 496-502.
22. Lefebvre C, Ranee A, Paul JF, Beguin C, Bletry O, Amoura Z et al. The role of B-mode ultrasonography and electron beam computed tomography in evaluation of Takayasu's arteritis: a study of 43 patients. Semin Arthritis Rheum. 2000; 30: 25-32.
23. Andrews J, Al-Nahhas A, Pennell DJ, Hossain MS, Davies KA, Haskard DO et al. Non-invasive imaging in the diagnosis and management of Takayasu's arteritis. Ann Rheum Dis. 2004; 63: 995-1000.
24. Walter MA, Melzer RA, Schindler C, Muller-Brand J, Tyndall A, Nitzsche EU. The value of [18F]FDG-PET in the diagnosis of large-vessel vasculitis and the assessment of activity and extent of disease. Eur J Nucl Med Mol Imaging. 2005; 32: 674-81.
25. Ishikawa K. Diagnostic approach and proposed criteria for the clinical diagnosis of Takayasu's arteriopathy. J Am Coll Cardiol. 1988; 12: 964-72.
26. Moriwaki R, Noda M, Yajima M, Sharma BK, Numano F. Clinical manifestations of Takayasu arteritis in India and Japan - new classification of angiographic findings. Angiology. 1997; 48: 369-79.
27. Launay D, Hachulla E. Aortite inflammatoire. Presse Med. 2004; 33: 1334-40.
28. Michel BA, Arend WP, Hunder GG. Clinical differentiation between giant cell (temporal) arteritis and Takayasu's arteritis. J Rheumatol. 1996; 23: 106-11.
29. Shelhamer JH, Volkman DJ, Parrillo JE, Lawley TJ, Johnston MR, Fauci AS. Takayasu's arteritis and its therapy. Ann Intern Med. 1985; 103: 121-6.
30. Sabbadini MG, Bozzolo E, Baldissera E, Bellone M. Takayasu's arteritis: therapeutic strategies. J Nephrol. 2001; 14: 525-31.
31. Hoffman GS, Leavitt RY, Kerr GS, Rottem M, Sneller MC, Fauci AS. Treatment of glucocorticoid-resistant or relapsing Takayasu arteritis with methotrexate. Arthritis Rheum. 1994; 37: 578-82.
32. Daina E, Schieppati A, Remuzzi G. Mycophenolate mofetil for the treatment of Takayasu arteritis: report of three cases. Ann Intern Med. 1999; 130: 422-6.
33. Hoffman GS, Merkel PA, Brasington RD, Lenschow DJ, Liang P. Anti-tumor necrosis factor therapy in patients with difficult to treat Takayasu arteritis. Arthritis Rheum. 2004; 50: 2296-304.
34. Ishikawa K. Effects of prednisolone therapy on arterial angiographic features in Takayasu's disease. Am J Cardiol. 1991; 68: 410-3
35. Sharma BK, Jain S, Bali HK, Jain A, Kumari S. A follow-up study of balloon angioplasty and de-novo stenting in Takayasu arteritis. Int J Cardiol. 2000 (Suppl 1); 75: S147-52.
36. Min PK, Park S, Jung JH, Ko YG, Choi D, Jang Y et al. Endovascular therapy combined with immunosuppressive treatment for occlusive arterial disease in patients with Takayasu's arteritis. J Endovasc Ther. 2005; 12: 28-34.
37. Liang P, Tan-Ong M, Hoffman GS. Takayasu's arteritis: vascular interventions and outcomes. J Rheumatol. 2004; 31: 102-6.
38. Liang P, Hoffman GS. Advances in the medical and surgical treatment of Takayasu arteritis. Curr Opin Rheumatol. 2005; 17: 16-24.
39. Miyata T, Sato O, Koyama H, Shigematsu H, Tada Y. Long-term survival after surgical treatment of patients with Takayasu's arteritis. Circulation. 2003; 108: 1474-80.
40. Mwipatayi PB, Jeffery PC. Beningfield SJ, Matley PJ, Naidoo NG, Kalla AA et al. Takayasu arteritis: clinical features and management: report of 272 cases. ANZ J Surg. 2005; 75: 110-7.
41. Ishikawa, Maetnai S. Long-term outcome for 120 Japanese patients with Takayasu's disease. Clinical and statistical analyses of related prognostic factors. Circulation. 1994; 90: 1855-60.
42. Wong VC, Wang RY, Tse TF. Pregnancy and Takayasu's arteritis. Am J Med. 1983; 75: 597-601.
43. Sharma BK, Jain S, Vasishta K. Outcome of pregnancy in Takayasu's arteritis. Int J Cardiol. 2000; 75: S159-62
44. Hoffman GS, Ahmed AE. Surrogate markers of disease activity in patients with Takayasu arteritis. A preliminary report from The International Network for the Study of the Systemic Vasculitides (INSSYS). Int J Cardiol. 1998; 66 (Suppl 1): S191-4.
45. Luqmani RA, Bacon PA, Moots RJ, Janssen BA, Pall A, Emery P et al. Birmingham Vasculitis Activity Score (BVAS) in systemic necrotizing vasculitis. QJM. 1994; 87: 671-8.
46. Matsuyama A, Sakai N, Ishigami M, Hiraoka H, Kashine S, Hirata A et al. Matrix metalloproteinases as novel disease markers in Takayasu arteritis. Circulation. 2003; 108: 1469-73.
47. Tso E, Flamm SD, White RD, Schvartzman PR, Mascha E, Hoffman GS. Takayasu arteritis: utility and limitations of magnetic resonance imaging in diagnosis and treatment. Arthritis Rheum. 2002; 46: 1634-42.
48. Webb M, Chambers A, AL-Nahhas A, Mason JC, Maudlin L, Rahman L et al. The role of 18F-FDG PET in characterising disease activity in Takayasu arteritis. Eur J Nucl Med Mol Imaging. 2004; 31: 627-34.
49. Seko Y, Minota S, Kawasaki A, Shinkai Y, Maeda K, Yagita H et al. Perforin-secreting killer cell infiltration and expression of a 65-kD heat-shock protein in aortic tissue of patients with Takayasu's arteritis. J Clin Invest. 1994; 93: 750-8.
50. Seko Y, Sato O, Takagi A, Tada Y, Matsuo H, Yagita H et al. Restricted usage of T-cell receptor Valpha-Vbeta genes in infiltrating cells in aortic tissue of patients with Takayasu's arteritis. Circulation. 1996; 93: 1788-90.